Clinical Trials in Massachusetts

Showing 9341-9360 of 17,868 trials

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

NCT01585688

The primary objectives are to evaluate the safety and tolerability of hLL1-DOX, and to determine the maximum tolerated dose (MTD) regimen (in terms of a dose and its associated dosing schedule). The secondary objectives are to obtain information on efficacy, pharmacodynamics, pharmacokinetics, and immunogenicity, and to determine the optimal dose for subsequent studies.

Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia

Gilead Sciences13 participantsStarted Aug 2012

Newark, Delaware, United States • Orlando, Florida, United States • Goshen, Indiana, United States +3 more locations

COMPLETEDPhase 214 miles

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

NCT02161718

This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD).

SchizophreniaAlcohol Use Disorder

Alkermes, Inc.300 participantsStarted May 2014

Little Rock, Arkansas, United States • Springdale, Arkansas, United States • Anaheim, California, United States +68 more locations

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Find Trials by Condition in Massachusetts

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD

The (PIVOTAL) Study

Therapy for Undergraduate College Students Who Binge Drink and Are Depressed

Virtual Teaching Kitchen

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma

Manipulating the Microbiome in IBD by Antibiotics and FMT

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium